Chemomab Therapeutics Ltd. CMMB
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.69M | 10.37M | 9.37M | 10.56M | |
| Total Receivables | 3.27M | 195.00K | 1.10M | 1.27M | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 2.86M | -- | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | 148.00K | 140.00K | |
| Total Current Assets | 9.96M | 13.43M | 10.61M | 11.98M | |
|
|
|||||
| Total Current Assets | 9.96M | 13.43M | 10.61M | 11.98M | |
| Net Property, Plant & Equipment | 158.00K | 176.00K | 217.00K | 501.00K | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 123.00K | 211.00K | 298.00K | 341.00K | |
| Total Assets | 10.24M | 13.81M | 11.13M | 12.82M | |
|
|
|||||
| Total Accounts Payable | 257.00K | 485.00K | 378.00K | 490.00K | |
| Total Accrued Expenses | 1.30M | 993.00K | 1.05M | 1.64M | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | 113.00K | |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | |
| Total Other Current Liabilities | -- | -- | -- | -- | |
| Total Current Liabilities | 1.55M | 1.48M | 1.43M | 2.25M | |
|
|
|||||
| Total Current Liabilities | 1.55M | 1.48M | 1.43M | 2.25M | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | 179.00K | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | -- | |
| Total Liabilities | 1.55M | 1.48M | 1.43M | 2.43M | |
|
|
|||||
| Common Stock & APIC | 124.24M | 123.95M | 117.70M | 116.34M | |
| Retained Earnings | -115.56M | -111.62M | -108.00M | -105.95M | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 8.69M | 12.33M | 9.70M | 10.39M | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 8.69M | 12.33M | 9.70M | 10.39M | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 8.69M | 12.33M | 9.70M | 10.39M | |
|
|
|||||